Your second pair of eyes
Clinical dermoscopy can be challenging, especially if you only practice it occasionally. Dermalyser is a CE-marked app that provides AI-driven decision support in seconds, by analysing a dermatoscopic image captured with your smartphone.
For medical professionals like
Primary Care Physicians
Dermatologists
General Practitioners
AI is here to support you, not replace you
Trusted by leading dermatologists. Developed in close collaboration with dermatologists and primary care physicians.
96% AUC
Clinically validated AI technique provides exceptional precision in skin lesion diagnostics.
56% Cost Savings
Less time per patient and no need for waiting on external experts' second opinion.
79% Fewer Referrals
More accurate assessments lead to fewer false positives and reduced overtreatment.
5 Sec Analysis
Immediate feedback during consultation, no waiting for results.
99.5% NPV
High confidence (Negative Predictive Value) in ruling out malignancy when a lesion is assessed as benign.
100% Doctors Decision
Dermalyser is an assistant, not a replacement. You always have the final word in diagnosis.
* Results reflect findings from Clinical Studies
Actual outcomes may vary depending on clinical workflow and implementation context.
AI Supported Medical Software
Created by and for doctors
Dermalyser is created by doctors, physicians, scientists and innovators with a clear purpose: to support healthcare professionals in providing the best possible diagnosis for their patients. Technology is not the end goal - it is a means to empower those who care for patients every day.
Accurate assessments (AUC)
Dermalyser
Expert Dermatologist
General Practitioner
Proven Clinical Impact
Enhance your clinical confidence
Data from clinical studies show improvements in diagnostic accuracy and patient flow. Decision always stays with you as a doctor, we're just adding some pace and peace of mind.
Partners & Collaborators
The Challenge
Primary care is increasingly challenged by high referral volumes to dermatology, large numbers of unnecessary excisions, and uncertainty for patients. This pathway is clinically unsustainable.
Our Solution
Dermalyser is an AI-driven 'second set of eyes' that supports clinicians with instant results using just a smartphone and dermatoscope. It is CE-marked, clinically validated, and helps doctors make accurate decisions, reduce unnecessary procedures, and reduce healthcare costs.
It is an exciting time in skin cancer care – AI diagnostic support, grounded in solid science and CE-marked, can not only raise the quality of care but also improve the working environment for healthcare professionals.
Sam Polesie
MD, Associate Professor, Adj. Senior Lecturer
Quick answers to common questions
Dermalyser is a CE-marked software that uses artificial intelligence to analyze digital dermatoscopic images of skin lesions. It functions as a decision-support tool for healthcare professionals when assessing suspected skin melanomas.
Only licenced healthcare professionals, such as general practitioners, primary care physicians, and dermatologists.
No. Dermalyser is a decision-support tool. The final diagnosis is always made by healthcare professionals.
A smartphone with the Dermalyser app, a compatible dermatoscope, and a clinical environment with trained healthcare staff.
Curious to see how Dermalyser could fit in your practice?
Discover how Dermalyser could support you and your profession today.
Book a Demo